147 related articles for article (PubMed ID: 37916054)
21. Uterine Artery Embolization for Retained Products of Conception with Marked Vascularity: A Safe and Efficient First-Line Treatment.
Bazeries P; Paisant-Thouveny F; Yahya S; Bouvier A; Nedelcu C; Boussion F; Sentilhes L; Willoteaux S; Aubé C
Cardiovasc Intervent Radiol; 2017 Apr; 40(4):520-529. PubMed ID: 28004170
[TBL] [Abstract][Full Text] [Related]
22. Hysteroscopic management of retained products of conception: A single center observational study.
Alonso Pacheco L; Timmons D; Saad Naguib M; Carugno J
Facts Views Vis Obgyn; 2019 Sep; 11(3):217-222. PubMed ID: 32082527
[TBL] [Abstract][Full Text] [Related]
23. Retained products of conception: What is the risk for recurrence on subsequent pregnancies?
Smorgick N; Mittler A; Ben-Ami I; Maymon R; Vaknin Z; Pansky M
Eur J Obstet Gynecol Reprod Biol; 2018 May; 224():1-5. PubMed ID: 29525517
[TBL] [Abstract][Full Text] [Related]
24. Long-term complications and reproductive outcome after the management of retained products of conception: a systematic review.
Hooker AB; Aydin H; Brölmann HA; Huirne JA
Fertil Steril; 2016 Jan; 105(1):156-64.e1-2. PubMed ID: 26453977
[TBL] [Abstract][Full Text] [Related]
25. Diagnosis of Acquired Uterine Arteriovenous Malformation by Doppler Ultrasound.
Scribner D; Fraser R
J Emerg Med; 2016 Aug; 51(2):168-71. PubMed ID: 27260690
[TBL] [Abstract][Full Text] [Related]
26. Hysteroscopic Management of Retained Products of Conception.
Lin YH; Cheng YY; Ding DC
Gynecol Minim Invasive Ther; 2018; 7(3):133-135. PubMed ID: 30254957
[TBL] [Abstract][Full Text] [Related]
27. Ultrasound diagnosis and management of acquired uterine enhanced myometrial vascularity/arteriovenous malformations.
Timor-Tritsch IE; Haynes MC; Monteagudo A; Khatib N; Kovács S
Am J Obstet Gynecol; 2016 Jun; 214(6):731.e1-731.e10. PubMed ID: 26873276
[TBL] [Abstract][Full Text] [Related]
28. Management of Hypervascular Retained Products of Conception With Massive Bleeding.
Shimada T; Wakimoto Y; Kamihigashi M; Tanaka H; Shibahara H
Cureus; 2023 Sep; 15(9):e45952. PubMed ID: 37885542
[TBL] [Abstract][Full Text] [Related]
29. See-and-treat in-office hysteroscopy versus operative hysteroscopy for the treatment of retained products of conception: A retrospective study.
Raz N; Sigal E; Gonzalez Arjona F; Calidona C; Garzon S; Uccella S; Laganà AS; Haimovich S
J Obstet Gynaecol Res; 2022 Sep; 48(9):2459-2465. PubMed ID: 35698805
[TBL] [Abstract][Full Text] [Related]
30. The Intrauterine Bigatti Shaver System: An Alternative Option for Focal Retained Products of Conception.
Sutherland NSV; Rajesh H
Case Rep Obstet Gynecol; 2018; 2018():1536801. PubMed ID: 30584483
[TBL] [Abstract][Full Text] [Related]
31. Intercoat (Oxiplex/AP gel) for preventing intrauterine adhesions after operative hysteroscopy for suspected retained products of conception: double-blind, prospective, randomized pilot study.
Fuchs N; Smorgick N; Ben Ami I; Vaknin Z; Tovbin Y; Halperin R; Pansky M
J Minim Invasive Gynecol; 2014; 21(1):126-30. PubMed ID: 23954387
[TBL] [Abstract][Full Text] [Related]
32. Ultrasound for diagnosis of postpartum retained products of conception-How accurate we are?
Yagur Y; Jurman L; Weitzner O; Arbib N; Markovitch O; Klein Z; Daykan Y; Schonman R
BMC Pregnancy Childbirth; 2023 Aug; 23(1):572. PubMed ID: 37563560
[TBL] [Abstract][Full Text] [Related]
33. Primary and secondary postpartum haemorrhage: a review for a rationale endovascular approach.
Alonso-Burgos A; Díaz-Lorenzo I; Muñoz-Saá L; Gallardo G; Castellanos T; Cardenas R; Chiva de Agustín L
CVIR Endovasc; 2024 Feb; 7(1):17. PubMed ID: 38349501
[TBL] [Abstract][Full Text] [Related]
34. Diagnosis and management of patients with enhanced myometrial vascularity associated with retained products of conception.
Groszmann YS; Healy Murphy AL; Benacerraf BR
Ultrasound Obstet Gynecol; 2018 Sep; 52(3):396-399. PubMed ID: 29124818
[TBL] [Abstract][Full Text] [Related]
35. Conservative and timely treatment in retained products of conception: a case report of placenta accreta ritention.
Guarino A; Di Benedetto L; Assorgi C; Rocca A; Caserta D
Int J Clin Exp Pathol; 2015; 8(10):13625-9. PubMed ID: 26722586
[TBL] [Abstract][Full Text] [Related]
36. Is Hysteroscopy the Best Surgical Approach for Removal of Retained Products of Conception Following Surgical Termination of Pregnancy?
Smorgick N; Kostin S; Tzur T; Levinsohn-Tavor O; Maymon R; Vaknin Z
J Obstet Gynaecol Can; 2020 Aug; 42(8):953-956. PubMed ID: 32386964
[TBL] [Abstract][Full Text] [Related]
37. A novel method for office aspiration curettage in cases of retained products of conception: A randomized controlled trial.
Pomeranz M; Goren Gepstein N; Ovadia M; Klein Z; Daykan Y; Schonman R; Arbib N
Acta Obstet Gynecol Scand; 2021 Nov; 100(11):2076-2081. PubMed ID: 34467531
[TBL] [Abstract][Full Text] [Related]
38. Postpartum retained products of conception: Retrospective analysis of the association with third stage of labor placental complications.
Smorgick N; Ayashi N; Levinsohn-Tavor O; Wiener Y; Betser M; Maymon R
Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():108-111. PubMed ID: 30682599
[TBL] [Abstract][Full Text] [Related]
39. Management of retained products of conception with marked vascularity.
Kitahara T; Sato Y; Kakui K; Tatsumi K; Fujiwara H; Konishi I
J Obstet Gynaecol Res; 2011 May; 37(5):458-64. PubMed ID: 21208344
[TBL] [Abstract][Full Text] [Related]
40. Use of hysteroscopy in diagnosis and follow-up of acquired uterine enhanced myometrial vascularity.
Gingold JA; Bradley LD
Fertil Steril; 2020 Feb; 113(2):460-462. PubMed ID: 32106997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
